Marc Rodger

Active 2000–2026

106
Papers
24,563
Citations
80
h-index
103
i10-index

Citations

Citations per year for Marc Rodger1910: 2 citations1964: 1 citations1975: 1 citations1997: 1 citations1998: 4 citations2001: 9 citations2002: 13 citations2003: 36 citations2004: 60 citations2005: 59 citations2006: 62 citations2007: 68 citations2008: 112 citations2009: 122 citations2010: 125 citations2011: 133 citations2012: 164 citations2013: 135 citations2014: 171 citations2015: 137 citations2016: 180 citations2017: 138 citations2018: 145 citations2019: 534 citations2020: 667 citations2021: 622 citations2022: 450 citations2023: 357 citations2024: 600 citations2025: 187 citations2026: 29 citations1911–1963: no citations, so these years are not shown1965–1974: no citations, so these years are not shown1976–1996: no citations, so these years are not shown1999–2000: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,449 citing papers, 20.1% of this breakdownCanada: 708 citing papers, 9.8% of this breakdownUnited Kingdom: 538 citing papers, 7.5% of this breakdownNetherlands: 442 citing papers, 6.1% of this breakdownItaly: 400 citing papers, 5.5% of this breakdownFrance: 366 citing papers, 5.1% of this breakdownChina: 346 citing papers, 4.8% of this breakdownGermany: 308 citing papers, 4.3% of this breakdownSwitzerland: 248 citing papers, 3.4% of this breakdownAustralia: 204 citing papers, 2.8% of this breakdownSpain: 193 citing papers, 2.7% of this breakdownAustria: 129 citing papers, 1.8% of this breakdown
0%20.1%Other 26.1%

Fields

  • Medicine88.1%
  • Decision Sciences2.4%
  • Biochemistry, Genetics and Molecular Biology2.3%
  • Health Professions1.4%
  • Immunology and Microbiology1.1%
  • Pharmacology, Toxicology and Pharmaceutics1%
  • Other3.7%

Topics

  • Venous Thromboembolism Diagnosis and Management19.7%
  • Atrial Fibrillation Management and Outcomes7.3%
  • Blood Coagulation and Thrombosis Mechanisms6.4%
  • Diagnosis and Treatment of Venous Diseases2.7%
  • Pregnancy and preeclampsia studies2.6%
  • Central Venous Catheters and Hemodialysis2.4%
  • Other58.9%

Coauthors

All papers

Open in search
  1. Venous thromboembolism

    Authors: , , , - The Lancet 2021 cited by 708

  2. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 847

  3. Predatory journals: no definition, no defence

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Sylos Labini, Robyn Tamblyn, Marthie van Niekerk, Jelte M. Wicherts, Manoj M. Lalu - Nature 2019 cited by 726

  4. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy

    Authors: , , , , , , , , , , , , , - Blood Advances 2018 cited by 596

  5. Evaluation of D-Dimer in the Diagnosis of Suspected Deep-Vein Thrombosis

    Authors: , , , , , , , , , - New England Journal of Medicine 2003 cited by 1,548

  6. Pulmonary embolism

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2018 cited by 331

  7. Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer

    Authors: , , , , , , , , , , , , - Thrombosis and Haemostasis 2000 cited by 1,644

  8. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , - BMJ 2019 cited by 313

  9. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 439

  10. Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical Model and d-dimer

    Authors: , , , , , , , , , - Annals of Internal Medicine 2001 cited by 1,427

  11. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Gebel, Michael Grosso, Kednapa Thavorn, Brian Hutton, Grégoire Le Gal, Dean Fergusson, Marc Rodger, MAJESTIC Collaborators, Faizan Khan, Tobias Tritschler, Miriam Kimpton, Philip S. Wells, Clive Kearon, Jeffrey I. Weitz, Harry R. Büller, Gary E. Raskob, Walter Ageno, Francis Couturaud, Paolo Prandoni, Gualtiero Palareti, Cristina Legnani, Paul A. Kyrle, Sabine Eichinger, Lisbeth Eischer, Cecilia Becattini, Giancarlo Agnelli, Maria Cristina Vedovati, Geert-Jan Geersing, Toshihiko Takada, Benilde Cosmi, Drahomir Aujesky, Letizia Marconi, Antonio Palla, Sergio Siragusa, Charlotte A. Bradbury, Sameer Parpia, Ranjeeta Mallick, Anthonie W.A. Lensing, Martin Gebel, Michael A. Grosso, Kednapa Thavorn, Brian Hutton, Gregoire Le Gal, Dean A. Fergusson, Marc A. Rodger - Annals of Internal Medicine 2021 cited by 138

  12. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism

    Authors: , , , , , , , , , , , , , , , - CHEST Journal 2016 cited by 275

  13. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wessel Ganzevoort, François Goffinet, Jiska M de Haan-Jebbink, Wieteke M. Heidema, Monique A Hertzberg, Marcel M.C. Hovens, Menno V. Huisman, Leonie de Jong-Speksnijder, Pieter W. Kamphuisen, Denis J O'Keeffe, Karine Lacut, Josje Langenveld, M Simone Lunshof, Caroline P. Martens, A. Merah, Emmanuelle Le Moigne, Dimitri N.M. Papatsonis, Gilles Pernod, F. Perrotin, Edith Peynaud-Debayle, Fabrice Pierre, Geneviève Bureau, Tiphaïne Raia-Barjat, Robbert JP Rijnders, Roger Rosario, M. Ruivard, Jeannot Schmidt, Marieke Sueters, Thomas Vanassche, Marie-Noëlle Varlet, Alexandre Vivanti, Matthieu Y. van der Vlist, Lucet F. van der Voet, Karlijn C. Vollebregt, Johanna I. de Vries, Sabina de Weerd, Peter E. Westerweel, Lia DE Wijnberger, Marije ten Wolde, Paula F. Ypma, Catherine Zuily-Lamy, Joost J. Zwart, Alexandra Benachi, G. Beucher, H. Bézanahary, Karin Boer, Marjon A. de Boer, Frantz Bousquet, Henk A. Bremer, Luc Bressollette, Aurélie Brossard, Cécile Chau, Brian Cleary, Fabienne Comte, Thomas Corsini, Anne Coustel, Barbara Debaveye, Raoul Desbrière, Cécile Duvillard, A. Eckman, Jeroen Eikenboom, Antoine Élias, Laura M. Faber, Émile Ferrari, Denis Gallot, Emilie Gauchotte, Ingrid Gaugler, Abby E. Geerlings, Audrey O'Gorman, Vincent Grobost and 41 more - The Lancet 2022 cited by 111

  14. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy

    Authors: , , , , , , , , , , , , , - Canadian Medical Association Journal 2008 cited by 579

  15. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism

    Authors: , , , , - Journal of Thrombosis and Thrombolysis 2016 cited by 435

  16. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

    Authors: , , , , , , , , , , , , , , - BMJ 2017 cited by 235

  17. Development of a Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism in Patients With Cancer-Associated Venous Thromboembolism

    Authors: , , , , , , , , , , - Circulation 2012 cited by 226

  18. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial

    Authors: , , , , , , , , , , , , , - BMJ 2021 cited by 103

  19. A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,147

  20. Venous Thromboembolism and Antithrombotic Therapy in Pregnancy

    Authors: , , , , , , , , , , , , - Journal of Obstetrics and Gynaecology Canada 2014 cited by 305

  21. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2013 cited by 523

  22. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia

    Authors: , , , , , - PLoS ONE 2017 cited by 230

  23. Quality of Life, Dyspnea, and Functional Exercise Capacity Following a First Episode of Pulmonary Embolism: Results of the ELOPE Cohort Study

    Authors: , , , , , , , , , , , , , , - The American Journal of Medicine 2017 cited by 164

  24. Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet 2016 cited by 227